Akero has been acquired by Novo Nordisk.

View press release
View press release
Akero Therapeutics logo
  • Contact
  • Linked
  • Twitter
  • About
    • Our Company
    • Our History
    • Leadership
    • Contact
  • Focus
    • Therapeutic Areas
    • Publications & Posters
  • Efruxifermin (EFX)
  • Clinical Trials
    • Clinical Trials Overview
    • Patients & Caregivers
  • Careers & News
    • Our Culture
    • Job Opportunities
    • News
  • Investors
Select Page
Akero Therapeutics logo
    • About
      • Our Company
      • Our History
      • Leadership
      • Contact
    • Focus
      • Therapeutic Areas
      • Publications & Posters
    • Efruxifermin (EFX)
    • Clinical Trials
      • Clinical Trials Overview
      • Patients & Caregivers
    • Careers & News
      • Our Culture
      • Job Opportunities
      • News
    • Investors
    • Contact
    • Linked
    • Twitter
A group meets for a presentation in a glass-walled conference room, while a woman talks on the phone in the background

Our Jobs

Back
Akero team posing with photo booth props at an event for Global Fatty Liver Day

Having fun is a key ingredient to our success.

Learn About Our Culture
  • About
  • Our Company
  • Our History
  • Leadership
  • Contact
  • Focus
  • Therapeutic Areas
  • Publications & Posters
  • Pipeline
  • Development Pipeline
  • Efruxifermin (EFX)
  • Clinical Trials
  • Clinical Trials Overview
  • Patients & Caregivers
  • Careers
  • Our Culture
  • Job Opportunities
  • News
  • Investors
Akero Therapeutics logo
©2025 Akero Therapeutics, Inc.
  • Privacy Policy
  • Terms of Use
  • Linked
  • Twitter